Nautilus Biotechnolgy
NAUT
NAUT
72 hedge funds and large institutions have $245M invested in Nautilus Biotechnolgy in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.56% more ownership
Funds ownership: 31.46% → 33.02% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
35% less capital invested
Capital invested by funds: $380M → $245M (-$135M)
Holders
72
Holding in Top 10
3
Calls
$1M
Puts
$310K
Top Buyers
| 1 | +$6.14M | |
| 2 | +$4.35M | |
| 3 | +$3.6M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$2.37M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.97M |
Top Sellers
| 1 | -$5.65M | |
| 2 | -$3.22M | |
| 3 | -$2.7M | |
| 4 |
CC
Casdin Capital
New York
|
-$1.69M |
| 5 |
Jane Street
New York
|
-$992K |